Corporate Governance

Neurocrine Biosciences, Inc.

To view the Audit Committee Charter, please click here. (PDF)

To view the Compensation Committee Charter, please click here. (PDF)

To view the Nominating / Corporate Governance Committee Charter, please click here. (PDF)

To view the Science and Medical Technology Committee Charter, please click here. (PDF)

To view the Corporate Governance Guidelines, please click here. (PDF)

To view the Code of Business Conduct and Ethics, please click here. (PDF)

To view the Policy for Recoupment of Incentive Compensation, please click here. (PDF)

To view the Neurocrine Comprehensive Compliance Program, please click here. (PDF)

To view the Declaration of Compliant Interactions with Healthcare Providers, please click here. (PDF)

To view SEC filings, please click here.

To view the Vermont Prescriber Information, Long Form (PDF) please click here and for the Short Form (PDF) click here for the Notice to Vermont Prescribers. The Vermont “Pharmaceutical Marketer Price Disclosure Law (33 V.S.A. 2005a)”, requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of drugs they market as well as the prices of other drugs in the same therapeutic class.  This information for Neurocrine Biosciences, Inc. products is provided.


The Board of Directors of Neurocrine Biosciences has adopted a Code of Business Conduct and Ethics applicable to employees, directors, consultants and vendors, a link to which can be found above on this page. The Board has also established an ethics hotline for reporting potential violations of this Code.

If you have any questions or concerns, you can contact the Neurocrine Ethics Hotline at 800-688-2908 or NeurocrineEthics.com.